Tema Oncology ETF
$42.29-$0.06 (-0.15%)
Tema Oncology ETF’s quoted price sits in the upper half of its reported 52-week range, 10.02% below the high.
AMEX · MINV · USD
Stock price, dividends
Quote as of Oct 30, 2026, 07:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Matthews Asia Innovators Active ETF’s quoted price sits in the lower half of its reported 52-week range, 29.97% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Matthews Asia Innovators Active ETF’s forward annual dividend is $0.53 per share, paid annual. The forward yield is 1.25% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
Matthews International Funds - Matthews Asia Innovators Active ETF is an exchange traded fund launched and managed by Matthews International Capital Management, LLC. The fund invests in public equity markets of Asia ex Japan region. It invests in stocks of companies operating across diversified sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It employs fundamental analysis to create its portfolio. It seeks to benchmark the performance of its portfolio against the MSCI All Country Asia ex Japan Index. Matthews International Funds - Matthews Asia Innovators Active ETF was formed on July 13, 2022 and is domiciled in the United States.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 12:33 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$42.29-$0.06 (-0.15%)
Tema Oncology ETF’s quoted price sits in the upper half of its reported 52-week range, 10.02% below the high.
$75.52-$0.89 (-1.16%)
Calvert US Mid-Cap Core Responsible Index ETF’s quoted price sits in the upper half of its reported 52-week range, 4.37% below the high.
$126.40-$2.15 (-1.67%)
Invesco S&P Spin-Off ETF’s quoted price sits in the upper half of its reported 52-week range, 15.98% below the high.
$30.46+$1.16 (+3.95%)
RockCreek Global Equality ETF’s quoted price sits in the upper half of its reported 52-week range, 4.34% below the high.
$12.65-$0.44 (-3.36%)
Amplify Lithium & Battery Technology ETF’s quoted price sits in the lower half of its reported 52-week range, 30.03% below the high.
$30.72-$0.15 (-0.47%)
Pacer Swan SOS Conservative (April) ETF’s quoted price sits in the upper half of its reported 52-week range, 0.47% below the high.
$38.06-$0.18 (-0.46%)
WisdomTree Europe Quality Dividend Growth Fund’s quoted price sits in the upper half of its reported 52-week range, 6.23% below the high.
$25.03-$0.48 (-1.86%)
KraneShares Electric Vehicles & Future Mobility Index ETF’s quoted price sits in the lower half of its reported 52-week range, 34.35% below the high.